<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03951779</url>
  </required_header>
  <id_info>
    <org_study_id>18-005354</org_study_id>
    <nct_id>NCT03951779</nct_id>
  </id_info>
  <brief_title>Diagnostic Utility of Exercise Cardiac Magnetic Resonance in the Assessment of Cardiac Dyspnea.</brief_title>
  <official_title>Diagnostic Utility of Exercise Cardiac Magnetic Resonance in the Assessment of Cardiac Dyspnea.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are examining the diagnostic utility of an exercise cardiac MRI (eCMR) in the
      assessment of cardiac dyspnea (shortness of breath).
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">December 14, 2018</start_date>
  <completion_date type="Anticipated">January 4, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ejection Fraction</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured using exercise cardiac magnetic resonance imaging (eCMR) reported in percentages</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke Volume</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured using exercise cardiac magnetic resonance imaging (eCMG) reported in mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Longitudinal Strain Assessment</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured using exercise cardiac magnetic resonance imaging (eCMG) reported in percentages</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Shortness of Breath</condition>
  <condition>Cardiac; Dyspnea</condition>
  <arm_group>
    <arm_group_label>Subjects with unexplained but suspected cardiac dyspnea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with unexplained but suspected cardiac dyspnea who are being scheduled for right heart catheterization will undergo an exercise cardiac magnetic resonance imaging (eCMR).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Exercise cardiac magnetic resonance imaging</intervention_name>
    <description>Subjects will exercise on a treadmill and immediately following the completion of the stress protocol, subjects will undergo cardiac magnetic resonance imaging</description>
    <arm_group_label>Subjects with unexplained but suspected cardiac dyspnea</arm_group_label>
    <other_name>eCMR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients aged ≥18 years years with suspected cardiac dyspnea who are
             scheduled to undergo right heart catheterization as dictated by a comprehensive
             examination and echocardiography will be included for enrollment.

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Pregnancy

          -  Mechanical ventilation

          -  Acute or chronic renal failure (creatinine clearance &lt;30 ml/min or requiring renal
             replacement therapy)

          -  Inability to perform MRI (i.e. claustrophobia, severe obesity (&gt;150 kg), device
             incompatible with MRI)

          -  Inability to exercise

          -  Significant arrhythmia that precludes adequate ECG-gating for the MRI (i.e. atrial
             fibrillation with highly variable cycle lengths)

          -  Prior heart or lung transplantation

          -  Left ventricular systolic (ejection fraction &lt;50%) or diastolic failure (based on
             Framingham criteria for heart failure with preserved ejection fraction)

          -  Significant left-sided valvular disease (≥moderate aortic stenosis, mitral stenosis,
             aortic regurgitation, mitral regurgitation) or prior valve surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian P Shapiro</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 14, 2019</study_first_submitted>
  <study_first_submitted_qc>May 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2019</study_first_posted>
  <last_update_submitted>April 24, 2020</last_update_submitted>
  <last_update_submitted_qc>April 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Brian Shapiro</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

